Vascepa and Night sweats - a phase IV clinical study of FDA data

Summary:

Night sweats is reported as a side effect among people who take Vascepa (icosapent ethyl), especially for people who are male, 60+ old, also take Vitamin B12, and have Prostate cancer.

The phase IV clinical study analyzes which people have Night sweats when taking Vascepa. It is created by eHealthMe based on reports of 5,777 people who have side effects when taking Vascepa from the FDA, and is updated regularly.

What is Vascepa?

Vascepa has active ingredients of icosapent ethyl. It is often used in high blood cholesterol. eHealthMe is studying from 5,894 Vascepa users. Check the latest studies of Vascepa.

What is Night sweats?

Night sweats (sweating in night) is found to be associated with 1,528 drugs and 1,689 conditions by eHealthMe. Check the latest studies of Night sweats.

On Aug, 10, 2026

5,777 people reported to have side effects when taking Vascepa.
Among them, 14 people (0.24%) have Night sweats.

Among these 14 people:

What is the gender of people who have Night sweats when taking Vascepa? *

female: 38.46 %
male: 61.54 %

What is the age of people who have Night sweats when taking Vascepa? *

What are other drugs people take besides Vascepa? *

Vitamin B12: 5 people, 35.71%
Orgovyx: 4 people, 28.57%
Aspirin: 4 people, 28.57%
Calcium: 4 people, 28.57%
Vitamin D3: 4 people, 28.57%
Tamsulosin Hydrochloride: 4 people, 28.57%
Lisinopril And Hydrochlorothiazide: 4 people, 28.57%
Metoprolol Tartrate: 4 people, 28.57%
Magnesium: 3 people, 21.43%
Zocor: 2 people, 14.29%

What are other side effects people have besides Night sweats? *

Diarrhea: 7 people, 50.00%
Hot Flush (sudden feelings of heat): 7 people, 50.00%
Weight Increased: 6 people, 42.86%
Low Density Lipoprotein Increased (cholesterol increased in blood): 6 people, 42.86%
Joint Pain: 5 people, 35.71%
Appetite - Increased (increased appetite is when you want to eat much more often or in larger quantities than your body requires): 4 people, 28.57%
Back Pain: 4 people, 28.57%
Rashes (redness): 4 people, 28.57%
Blood Glucose Increased: 4 people, 28.57%
Haematochezia (passage of stools containing blood): 4 people, 28.57%

What are the existing conditions these people have? *

Prostate Cancer: 4 people, 28.57%
Hot Flush (sudden feelings of heat): 2 people, 14.29%
Cushing's Syndrome (obesity, a rounded face, increased fat): 2 people, 14.29%
Breast Cancer Female: 2 people, 14.29%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 2 people, 14.29%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 7.14%
Psoriasis (immune-mediated disease that affects the skin): 1 person, 7.14%
Pain: 1 person, 7.14%
Immunodeficiency Common Variable: 1 person, 7.14%
High Blood Pressure: 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Vascepa and have Night sweats?

- Check whether Night sweats is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Vascepa:

Vascepa (5,894 reports)

Night sweats treatments and more:

Night sweats (40,332 reports)

Browse all side effects of Vascepa:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Night sweats:

Night sweats (1,528 drugs)

Browse all the conditions that are associated with Night sweats:

Night sweats (1,689 conditions)

Related publications that referenced our studies

Murday HK, Rusli FD, Blandy C, Vollenhoven B, "Night sweats: it may be hemochromatosis", Climacteric, 2016 Jul .
Murday HK, Rusli FD, Blandy C, Vollenhoven B, "Night sweats: it may be hemochromatosis", Climacteric, 2016 Jul .

How the study uses the data?

The study uses data from the FDA. It is based on icosapent ethyl (the active ingredients of Vascepa) and Vascepa (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.